(RTTNews) - Bicycle Therapeutics plc (BCYC), Monday announced updated topline Phase 1 combination data for zelenectide pevedotin plus pembrolizumab in previously untreated (first-line) cisplatin ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback